Research reportSensory-motor performance after acute glutathione depletion by L-BUTHIONINE (cas 13073-21-7) sulfoximine injection into substantia nigra pars compacta
-
Add time:09/27/2019 Source:sciencedirect.com
Glutathione is the major antioxidant in the living cells. Its deficit has been linked to neurodegenerative disorders as Parkinson's disease but its role in the etiology of nigral degeneration and sensory-motor performance has been poorly explored. To evaluate the effect of glutathione depletion on nigro-striatal oxidative metabolism and sensory-motor performance in rats, L-BUTHIONINE (cas 13073-21-7) sulfoximine (15 mM) or saline solution was injected into substantia nigra pars compacta (SNpc). Then, oxidative metabolism was studied 24 h and 7 days later in SNpc and corpus striatum (CS). Tyrosine hydroxylase and GFAP immunohistochemistry assays were carried out at 7 days. In addition, animals were evaluated in open field, adhesive removal, staircase and traverse beam tests. Glutathione depletion induced compensatory response in catalase activity and glial response in the in SNpc and no oxidative damage was observed. However, a loss in dopaminergic cells was found. At the same time, animals with glutathione depletion have shown poor performance in behavioral tests except for staircase test. These results suggest that glutathione depletion can be related to sensory-motor dysfunction.
We also recommend Trading Suppliers and Manufacturers of L-BUTHIONINE (cas 13073-21-7). Pls Click Website Link as below: cas 13073-21-7 suppliers
Prev:l-S,R-buthionine sulfoximine: historical development and clinical issues
Next:Potential of L-BUTHIONINE (cas 13073-21-7) sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- original paperButhionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines09/30/2019
- Melanin content and downregulation of glutathione S-transferase contribute to the action of L-BUTHIONINE (cas 13073-21-7)-S-sulfoximine on human melanoma09/29/2019
- Original ContributionMechanisms of BSO (L-BUTHIONINE (cas 13073-21-7)-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma09/28/2019
- Potential of L-BUTHIONINE (cas 13073-21-7) sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer☆10/01/2019
- l-S,R-buthionine sulfoximine: historical development and clinical issues09/26/2019
- Thiol modulation and protectionPharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine09/25/2019
- Inhibition of glutathione production by L-S,R-buthionine sulfoximine activates hepatic ascorbate synthesis – A unique anti-oxidative stress mechanism in mice09/24/2019
- Systemic L-BUTHIONINE (cas 13073-21-7)-S-R-sulfoximine administration modulates glutathione homeostasis via NGF/TrkA and mTOR signaling in the cerebellum09/10/2019
- Research articleImpairment in exploratory behavior is associated with arc gene overexpression in the dorsolateral striatum of rats with nigral injection of L-BUTHIONINE (cas 13073-21-7) sulfoximine09/09/2019


